Targeting CD19 in diffuse large B‐cell lymphoma: An expert opinion paper-Reference-Cited by-同舟云学术

Targeting CD19 in diffuse large B‐cell lymphoma: An expert opinion paper

Published:2022-06-07 Issue:4 Volume:40 Page:505-517
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Bailly Sarah¹^ORCID,Cartron Guillaume²^ORCID,Chaganti Sridhar³,Córdoba Raul⁴^ORCID,Corradini Paolo⁵^ORCID,Düll Johannes⁶,Ferrarini Isacco⁷^ORCID,Osborne Wendy⁸^ORCID,Rosenwald Andreas⁹^ORCID,Sancho Juan‐Manuel¹⁰^ORCID,Tilly Hervé¹¹^ORCID,Van Den Neste Eric¹^ORCID,Viardot Andreas¹²^ORCID,Visco Carlo⁷^ORCID

Affiliation:

1. Département d’Hématologie Cliniques Universitaires Saint‐Luc Brussels Belgium

2. Department of Haematology Centre Hospitalier Universitaire de Montpellier UMR‐CNRS 5535 Montpellier France

3. Department of Haematology Queen Elizabeth Hospital Birmingham UK

4. Department of Hematology Fundación Jiménez Díaz University Hospital Health Research Institute IIS‐FJD Madrid Spain

5. Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan Milan Italy

6. Medizinische Klinik und Poliklinik II Universitätsklinikum Würzburg Würzburg Germany

7. Department of Medicine Section of Hematology University of Verona Verona Italy

8. Newcastle Upon Tyne Hospitals NHS Foundation Trust Newcastle UK

9. Institute of Pathology University of Würzburg, and Comprehensive Cancer Center Mainfranken Würzburg Germany

10. ICO‐IJC‐Hospital Germans Trias I Pujol Barcelona Spain

11. Department of Hematology and U1245 Centre Henri Becquerel and University of Rouen Rouen France

12. Department of Internal Medicine III University Hospital Ulm Ulm Germany

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3013

Reference130 articles.

1. Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

2. Racial differences in three major NHL subtypes: Descriptive epidemiology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia;Journal of Translational Medicine;2024-03-13

2. CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma;Journal of Personalized Medicine;2023-11-10

3. How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B‐cell lymphoma?;Hematological Oncology;2023-11-08

4. Targeting CD19-positive lymphomas with the antibody-drug conjugate (ADC) loncastuximab tesirine: preclinical evidence as single agent and as combinatorial approach;2023-08-18

5. Redefining Precision Management of r/r Large B-Cell Lymphoma: Novel Antibodies Take on CART and BMT in the Quest for Future Treatment Strategies;Cells;2023-07-14